SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-199246
Filing Date
2022-07-21
Accepted
2022-07-21 17:01:57
Documents
53
Period of Report
2022-07-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d379554d8k.htm   iXBRL 8-K 58769
2 EX-2.1 d379554dex21.htm EX-2.1 571689
3 EX-10.1 d379554dex101.htm EX-10.1 49054
4 EX-10.2 d379554dex102.htm EX-10.2 101255
5 EX-10.3 d379554dex103.htm EX-10.3 20908
6 EX-99.1 d379554dex991.htm EX-99.1 22487
7 EX-99.2 d379554dex992.htm EX-99.2 45925
8 EX-99.3 d379554dex993.htm EX-99.3 56034
9 EX-99.4 d379554dex994.htm EX-99.4 25449
13 GRAPHIC g379554ex99_2s10g1.jpg GRAPHIC 369654
14 GRAPHIC g379554ex99_2s11g1.jpg GRAPHIC 420531
15 GRAPHIC g379554ex99_2s12g1.jpg GRAPHIC 400504
16 GRAPHIC g379554ex99_2s13g1.jpg GRAPHIC 427304
17 GRAPHIC g379554ex99_2s14g1.jpg GRAPHIC 484627
18 GRAPHIC g379554ex99_2s15g1.jpg GRAPHIC 479711
19 GRAPHIC g379554ex99_2s16g1.jpg GRAPHIC 349312
20 GRAPHIC g379554ex99_2s17g1.jpg GRAPHIC 370927
21 GRAPHIC g379554ex99_2s18g1.jpg GRAPHIC 436624
22 GRAPHIC g379554ex99_2s19g1.jpg GRAPHIC 308458
23 GRAPHIC g379554ex99_2s1g1.jpg GRAPHIC 96056
24 GRAPHIC g379554ex99_2s20g1.jpg GRAPHIC 476387
25 GRAPHIC g379554ex99_2s21g1.jpg GRAPHIC 341322
26 GRAPHIC g379554ex99_2s22g1.jpg GRAPHIC 354593
27 GRAPHIC g379554ex99_2s23g1.jpg GRAPHIC 360235
28 GRAPHIC g379554ex99_2s24g1.jpg GRAPHIC 365762
29 GRAPHIC g379554ex99_2s25g1.jpg GRAPHIC 281803
30 GRAPHIC g379554ex99_2s26g1.jpg GRAPHIC 410717
31 GRAPHIC g379554ex99_2s27g1.jpg GRAPHIC 309680
32 GRAPHIC g379554ex99_2s28g1.jpg GRAPHIC 377410
33 GRAPHIC g379554ex99_2s29g1.jpg GRAPHIC 311351
34 GRAPHIC g379554ex99_2s2g1.jpg GRAPHIC 652188
35 GRAPHIC g379554ex99_2s30g1.jpg GRAPHIC 359839
36 GRAPHIC g379554ex99_2s31g1.jpg GRAPHIC 388433
37 GRAPHIC g379554ex99_2s32g1.jpg GRAPHIC 477425
38 GRAPHIC g379554ex99_2s33g1.jpg GRAPHIC 348217
39 GRAPHIC g379554ex99_2s3g1.jpg GRAPHIC 508045
40 GRAPHIC g379554ex99_2s4g1.jpg GRAPHIC 362444
41 GRAPHIC g379554ex99_2s5g1.jpg GRAPHIC 335143
42 GRAPHIC g379554ex99_2s6g1.jpg GRAPHIC 237864
43 GRAPHIC g379554ex99_2s7g1.jpg GRAPHIC 497903
44 GRAPHIC g379554ex99_2s8g1.jpg GRAPHIC 400897
45 GRAPHIC g379554ex99_2s9g1.jpg GRAPHIC 460076
  Complete submission text file 0001193125-22-199246.txt   18914576

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA sbtx-20220721.xsd EX-101.SCH 2861
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE sbtx-20220721_lab.xml EX-101.LAB 18739
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sbtx-20220721_pre.xml EX-101.PRE 11711
47 EXTRACTED XBRL INSTANCE DOCUMENT d379554d8k_htm.xml XML 3473
Mailing Address 500 FAIRVIEW AVENUE NORTH, SUITE 600 SEATTLE WA 98109
Business Address 500 FAIRVIEW AVENUE NORTH, SUITE 600 SEATTLE WA 98109 206-456-2900
Silverback Therapeutics, Inc. (Filer) CIK: 0001671858 (see all company filings)

IRS No.: 811489190 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39756 | Film No.: 221097686
SIC: 2834 Pharmaceutical Preparations